Study

EORTC-62012

Randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first line treatment of advanced or metastatic soft tissue sarcoma

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 08-Apr-2003
Date Step1 close: 25-May-2010

Data management at EORTC

Yes

Design

Phase 3
Randomized open label

Targeted Sample size

EORTC Groups: 450

Protocol summary

http://clinicaltrials.gov/study/NCT00061984

NCT number

NCT00061984

EudraCT

2004-002113-36